Can DCE-MRI Explain the Heterogeneity in Radiopeptide Uptake Imaged by SPECT in a Pancreatic Neuroendocrine Tumor Model?

被引:18
作者
Bol, Karin [1 ,2 ,3 ,4 ]
Haeck, Joost C. [1 ,2 ,3 ,4 ]
Groen, Harald C. [3 ,4 ]
Niessen, Wiro J. [1 ,2 ,3 ,5 ]
Bernsen, Monique R. [3 ,4 ]
de Jong, Marion [3 ,4 ]
Veenland, Jifke F. [1 ,2 ,3 ]
机构
[1] Erasmus MC, Dept Radiol, Biomed Imaging Grp Rotterdam, Rotterdam, Netherlands
[2] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands
[3] Erasmus MC, Dept Radiol, Rotterdam, Netherlands
[4] Erasmus MC, Dept Nucl Med, Rotterdam, Netherlands
[5] Delft Univ Technol, Fac Sci Appl, Delft, Netherlands
关键词
RECEPTOR RADIONUCLIDE THERAPY; RADIOLABELED SOMATOSTATIN ANALOG; INDIUM-111-PENTETREOTIDE; PARAMETERS; PERFUSION; TRACER;
D O I
10.1371/journal.pone.0077076
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Although efficient delivery and distribution of treatment agents over the whole tumor is essential for successful tumor treatment, the distribution of most of these agents cannot be visualized. However, with single-photon emission computed tomography (SPECT), both delivery and uptake of radiolabeled peptides can be visualized in a neuroendocrine tumor model overexpressing somatostatin receptors. A heterogeneous peptide uptake is often observed in these tumors. We hypothesized that peptide distribution in the tumor is spatially related to tumor perfusion, vessel density and permeability, as imaged and quantified by DCE-MRI in a neuroendocrine tumor model. Four subcutaneous CA20948 tumor-bearing Lewis rats were injected with the somatostatin-analog In-111-DTPA-Octreotide (50 MBq). SPECT-CT and MRI scans were acquired and MRI was spatially registered to SPECT-CT. DCE-MRI was analyzed using semi-quantitative and quantitative methods. Correlation between SPECT and DCE-MRI was investigated with 1) Spearman's rank correlation coefficient; 2) SPECT uptake values grouped into deciles with corresponding median DCE-MRI parametric values and vice versa; and 3) linear regression analysis for median parameter values in combined datasets. In all tumors, areas with low peptide uptake correlated with low perfusion/density//permeability for all DCE-MRI-derived parameters. Combining all datasets, highest linear regression was found between peptide uptake and semi-quantitative parameters (R-2>0.7). The average correlation coefficient between SPECT and DCE-MRI-derived parameters ranged from 0.52-0.56 (p<0.05) for parameters primarily associated with exchange between blood and extracellular extravascular space. For these parameters a linear relation with peptide uptake was observed. In conclusion, the 'exchange-related' DCE-MRI-derived parameters seemed to predict peptide uptake better than the 'contrast amount-related' parameters. Consequently, fast and efficient diffusion through the vessel wall into tissue is an important factor for peptide delivery. DCE-MRI helps to elucidate the relation between vascular characteristics, peptide delivery and treatment efficacy, and may form a basis to predict targeting efficiency.
引用
收藏
页数:11
相关论文
共 33 条
[1]   Heterogeneity in DCE-MRI parametric maps: a biomarker for treatment response? [J].
Alic, L. ;
van Vliet, M. ;
van Dijke, C. F. ;
Eggermont, A. M. M. ;
Veenland, J. F. ;
Niessen, W. J. .
PHYSICS IN MEDICINE AND BIOLOGY, 2011, 56 (06) :1601-1616
[2]   Quantifying heterogeneity in human tumours using MRI and PET [J].
Asselin, Marie-Claude ;
O'Connor, James P. B. ;
Boellaard, Ronald ;
Thacker, Neil A. ;
Jackson, Alan .
EUROPEAN JOURNAL OF CANCER, 2012, 48 (04) :447-455
[3]  
Bodei L, 2010, EUR REV MED PHARMACO, V14, P347
[4]  
BREEMAN WAP, 1995, J NUCL MED, V36, P623
[5]   Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI [J].
Buckley, DL .
MAGNETIC RESONANCE IN MEDICINE, 2002, 47 (03) :601-606
[6]   111In-labelled somatostatin analogues in a rat tumour model:: somatostatin receptor status and effects of peptide receptor radionuclide therapy [J].
Capello, A ;
Krenning, E ;
Bernard, B ;
Reubi, JC ;
Breeman, W ;
de Jong, M .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 (11) :1288-1295
[7]   Somatostatin receptor imaging for neuroendocrine tumors [J].
de Herder W.W. ;
Kwekkeboom D.J. ;
Feelders R.A. ;
van Aken M.O. ;
Lamberts S.W.J. ;
van der Lely A.-J. ;
Krenning E.P. .
Pituitary, 2006, 9 (3) :243-248
[8]   Tumour uptake of the radiolabelled somatostatin analogue [DOTA0,TYR3]octreotide is dependent on the peptide amount [J].
de Jong, M ;
Breeman, WAP ;
Bernard, BF ;
van Gameren, A ;
de Bruin, E ;
Bakker, WH ;
van der Pluijm, ME ;
Visser, TJ ;
Mäcke, HR ;
Krenning, EP .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (07) :693-698
[9]   Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine turnors [J].
Delaunoit, T ;
Rubin, J ;
Neczyporenko, F ;
Erlichman, C ;
Hobday, TJ .
MAYO CLINIC PROCEEDINGS, 2005, 80 (04) :502-506
[10]   Differences in survival by histologic type of pancreatic cancer [J].
Fesinmeyer, MD ;
Austin, MA ;
Li, CI ;
De Roos, AJ ;
Bowen, DJ .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (07) :1766-1773